GlycoMimetics Announces New Uproleselan Clinical Data Will Be Presented at ASH Annual Meeting

Stock Information for GlycoMimetics Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About GlycoMimetics Inc.

GlycoMimetics Stockholders Approve Proposed Merger with Crescent Biopharma and All Related Proposals
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RDFN, LRFC, RDW, GLYC on Behalf of Shareholders
GLYCOMIMETICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of GlycoMimetics, Inc. - GLYC
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PRA, FARO, AVDX, GLYC on Behalf of Shareholders
$TOCKHOLDER ALERT: The M&A Class Action Firm Continues Its Investigation Into The Merger - GLYC, BRZH, PRA, FVNNU
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates COLB, PRA, GLYC on Behalf of Shareholders
$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger - GLYC, BRZH, PRA, FVNNU
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CMRX and GLYC on Behalf of Shareholders

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.